Global Health Limited (NSE: Medanta, BSE: 543654), one of the largest private multi-specialty tertiary care providers in North and East India, today announced its unaudited consolidated financial results for the quarter ended June 30, 2025, reporting its highest-ever Q1 performance.
Total income rose 19.1% year-on-year to ₹10,513 million, EBITDA increased 22.6% to ₹2,553 million, and Profit After Tax surged 49.6% to ₹1,590 million, with PAT margins improving to 15.1%. Key growth drivers included a 13.3% increase in occupied bed days, a 4% rise in ARPOB to ₹66,584, and double-digit growth in in-patient and out-patient volumes. Mature hospitals generated ₹7,006 million in revenue, while developing hospitals grew 35.9% to ₹3,219 million. International patient revenue climbed 33.8% to ₹636 million, and OPD pharmacy revenue grew 21.6% to ₹404 million.
Medanta’s upcoming Northeast expansion is poised to enhance advanced care access for Tripura’s residents. Currently dependent on Guwahati and Kolkata for complex treatments, the region stands to benefit from reduced medical travel and greater availability of specialized services locally. CEO Pankaj Sahni reaffirmed commitment to capacity expansion, citing the operational launch of a 110-bed hospital in Ranchi and the upcoming 550-bed Noida facility in Q2 FY26.
